Amgen Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (107)

Latest Posts

About This Stock More About This Stock
Is Now A Good Time To Buy Amgen?
Article By: Andres Cardenal
Monday, September 24, 2018 2:05 PM EDT
Amgen is a high-quality business generating strong cash flows. From a quantitative perspective, the numbers bode well for investors in Amgen going forward.
In this article: AMGN Also: NVO, IBB, BIIB, CELG
Read
Biotech ETFs In Focus On String Of Q2 Earnings Beats
Article By: Zacks Investment Research
Sunday, August 12, 2018 4:27 PM EDT
The biotech sector has been performing remarkably well driven by a wave of mergers and acquisitions, new tax legislation, and a positive regulatory backdrop. Strong Q2 earnings results have added to the strength as biotech giants topped estimates.
In this article: IBB, AMGN, GILD, BBH, FBT, ALXN, BIIB
Read
August 11, 20018 Week In Review: How Trump's Policies Moved Stocks
Article By: The Fly
Saturday, August 11, 2018 9:37 PM EDT
Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Trump and his administration with this weekly recap.
In this article: L, AA, AKS, BA, CLF, JNJ, NUE, X, DDAIF, RHHBY, REGN, AAPL, AMGN, CENX, STLD
Read
Week In Review: Two Hong Kong IPOs - BeiGene And Ascletis - Raise A Combined $1.3 Billion
Article By: ChinaBio® Today
Saturday, August 4, 2018 4:27 PM EDT
BeiGene, a Beijing oncology company, raised $900 million in a debut offering on the Hong Kong stock exchange. Ascletis Pharma of Hangzhou completed a $400 million IPO on the Hong Kong exchange at a $2 billion capitalization
In this article: AMGN, BGNE
Read
Biotechs Hold And Ignore Rocky Week Of Global Politics - Big Earnings Upcoming… Updates CELG, BIIB, AZN, XBI
Article By: Rod Raynovich
Saturday, July 28, 2018 9:15 PM EDT
Biotech and Tech stocks teetered near highs for the year despite all the political drama of Putin and Trump at Helsinki, Russian “Spy” at the NRA, Tariffs and Trade War, Brexit Uncertainty, currency volatility and the Powell FED rate hike policy.
In this article: AZN, BIIB, LLY, CELG, RHHBY, VRTX, BMY, AMGN, GILD, ABBV, HON, JNJ, AGIO
Read

PARTNER HEADLINES

Latest Tweets for $AMGN

No tweets yet!

$AMGN

July 2017 Stock Considerations
Dick Kaplan 7/3/2017 3:14:44 AM

I read that #Repatha sales for this quarter are down significantly so be careful with $AMGN.

1 to 1 of 1 comments